疫苗诱发的免疫血栓性血栓性缺血:我们到目前为止知道什么?
Renat Roytenberg1, Adolfo García-Sastre2,3,4,5,6, Wei Li1
1Department of Biomedical Sciences, Joan C. Edwards School of Medicine at Marshall University, Huntington, WV, United States.
Frontiers in medicine
|June 1, 2023
概括
疫苗诱发的免疫血栓性血栓性缺血症 (VITT) 是对COVID-19疫苗,特别是腺病毒载体疫苗的罕见但严重反应. 本综述探讨了VITT病原和抗PF4抗体形成背后的潜在机制.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 血液学 血液学 血液学
背景情况:
- 疫苗诱导的免疫血栓性血栓性缺血症 (VITT),或血栓性缺血症综合征的血栓症,是与COVID-19疫苗相关的严重不良事件.
- 在接种腺病毒载体 (AV) 疫苗后,VITT主要发生,但潜在的机制尚不清楚.
研究的目的:
- 为了审查VITT的病变发生.
- 提供有关推动PF4抗体形成和VITT病理学的机制的见解.
主要方法:
- 对VITT的当前实验数据和假设的审查.
- 分析抗血小板因子4 (PF4) 抗体和FcγRIIa在VITT病原发生中的作用.
主要成果:
- VITT涉及通过抗PF4抗体调解的血小板激活和耗尽.
- 据假设,PF4/polyanion复合体的形成是VITT病理学的关键驱动因素.
结论:
- 了解VITT的机制对于疫苗安全和患者管理至关重要.
- 需要进行进一步的研究,以阐明VITT中抗PF4抗体反应的确切触发因素.
相关概念视频
Vaccinations
44.9K
Overview
44.9K
Venous Thrombosis III: Interprofessional Care
12
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
12
Venous Thrombosis I: Introduction
14
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
14
Immune Response Against Viral Pathogens
837
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
837
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
17
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
17
Anticoagulant Drugs: Low-Molecular-Weight Heparins
773
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
773


